• Explore /
  • Poster
  • / Association between prior radical surgery (RS) and outcomes with immune checkpoint inhibitor (ICI) therapy for advanced urothelial carcinoma (aUC).

Association between prior radical surgery (RS) and outcomes with immune checkpoint inhibitor (ICI) therapy for advanced urothelial carcinoma (aUC).

Abstract Video & Slides Poster

Authors

null

Dimitrios Makrakis

The University of Washington School of Medicine, Seattle, WA

Dimitrios Makrakis , Daniel Castellano , Ivan de Kouchkovsky , Joseph J. Park , Mehmet Asim Bilen , Neeraj Agarwal , Yousef Zakharia , Rafael Morales-Barrera , Michael E. Devitt , Ariel Ann Nelson , Benjamin A. Gartrell , Abhishek Tripathi , Aristotelis Bamias , Alejo Rodriguez-Vida , Sandy Liu , Rana R. McKay , Lucia Andrea Alonso Buznego , Jure Murgic , Petros Grivas , Ali Raza Khaki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 444)

DOI

10.1200/JCO.2021.39.6_suppl.444

Abstract #

444

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Chase Allain Shipp

First Author: Karim Amrane Sr.

First Author: Rafee Talukder

Poster

2023 ASCO Genitourinary Cancers Symposium

Outcomes with immune checkpoint inhibitor (ICI) therapy in patients with FGFR2/3 alterations in advanced urothelial carcinoma (aUC).

Outcomes with immune checkpoint inhibitor (ICI) therapy in patients with FGFR2/3 alterations in advanced urothelial carcinoma (aUC).

First Author: Rafee Talukder